ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Featured Product
Elmo Motion Control - The Platinum Line, a new era in servo control
Significantly enhanced servo performance, higher EtherCAT networking precision, richer servo operation capabilities, more feedback options, and certified smart Functional Safety. Elmo's industry-leading Platinum line of servo drives provides faster and more enhanced servo performance with wider bandwidth, higher resolutions, and advanced control for better results. Platinum drives offer precise EtherCAT networking, faster cycling, high synchronization, negligible jitters, and near-zero latency. They are fully synchronized to the servo loops and feature-rich feedback support, up to three feedbacks simultaneously (with two absolute encoders working simultaneously). The Platinum Line includes one of the world's smallest Functional Safety, and FSoE-certified servo drives with unique SIL capabilities.
